Effect of fibrin clot on plasma enzyme activation
Sumi, H.; Takasugi, S.
Nihon Seirigaku Zasshi. Journal of the Physiological Society of Japan 40(3): 59-61
1978
ISSN/ISBN: 0031-9341 PMID: 151137 Document Number: 125929
Document emailed within 1 workday
Related Documents
Aoki, N. 1993: Clot retraction increases clot resistance to fibrinolysis by condensing alpha 2-plasmin inhibitor crosslinked to fibrin Thrombosis and Haemostasis 70(2): 376Rustamova, B.A.; Molchanova, L.V.; Kudriashov, B.A. 1970: The effect of heparin on fibrin clot stabilization Voprosy Meditsinskoi Khimii 16(3): 290-293
Colle, J.P.; Mishal, Z.; Lesty, C.; Mirshahi, M.; Peyne, J.; Baumelou, A.; Bensman, A.; Soria, J.; Soria, C. 1999: Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: influence of plasma biochemical modifications: a possible mechanism for the high thrombotic tendency? Thrombosis and Haemostasis 82(5): 1482-1489
Dolesobel, W. 1972: Use of new methods for studies of blood coagulation. II. Clot-sedimentation-technic for the determination of antithrombin i effect of fibrin Wiener Medizinische Wochenschrift 122(41): 585-590
Mirshahi, M.; Azzarone, B.; Soria, J.; Mirshahi, F.; Soria, C. 1991: The role of fibroblasts in organization and degradation of a fibrin clot Journal of Laboratory and Clinical Medicine 117(4): 274-281
Davey, F.R.; Gordon, G.B.; Boral, L.I.; Gottlieb, A.J. 1976: Gamma globulin inhibition of fibrin clot formation Annals of Clinical and Laboratory Science 6(1): 72-77
Goldfarb, R. 2002: Elevation of plasma peptidoglycan and peripheral blood neutrophil activation during hemorrhagic shock: plasma peptidoglycan reflects bacterial translocation and may effect neutrophil activation Critical Care Medicine 30(1): 254-255
Doellgast, G.J.; Triscott, M.X.; Buss, D.H.; West, J. 1988: Extrinsic-pathway enzyme-linked coagulation assay (EP-ELCA). a clot-based alternative to prothrombin time for measurement of extrinsic pathway factors in plasma Clinical Chemistry 34(2): 294-299
Nicosia, R.F.; Tchao, R.; Leighton, J. 1983: Angiogenesis-dependent tumor spread in reinforced fibrin clot culture Cancer Research 43(5): 2159-2166
Andrew, M.; Brooker, L.; Leaker, M.; Paes, B.; Weitz, J. 1992: Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration Thrombosis and Haemostasis 68(3): 325-330
Mosesson, M.W.; Siebenlist, K.R.; Voskuilen, M.; Nieuwenhuizen, W. 1996: The effect of fibrinogen polymerization and crosslinking on exposure of fibrin-specific epitopes and t-PA mediated plasminogen activation Ukrainskii Biokhimicheskii Zhurnal 68(4): 37-38
Ishmukhametova, D.N.; Mozhina, A.A. 1984: Relation of the formation of the fibrin network of a blood clot to the amount of thrombin in complexes with endogenous heparin Anesteziologiia i Reanimatologiia 2: 30-34
Carr, M.E.; Gabriel, D.A. 1980: The effect of dextran 70 on the structure of plasma-derived fibrin gels Journal of Laboratory and Clinical Medicine 96(6): 985-993
Vorlová, Z.; Dyr, I.E. 1979: Effect of fibrin-fibrinogenolysis on the determination of the fibrinogen content and fibrin-fibrinogen degradation products (FDP) by means of the fibrin polymerization time (FPT test) Folia Haematologica 106(5-6): 967-970
Fingert, H.J.; Chen, Z.; Mizrahi, N.; Gajewski, W.H.; Bamberg, M.P.; Kradin, R.L. 1987: Rapid growth of human cancer cells in a mouse model with fibrin clot subrenal capsule assay Cancer Research 47(14): 3824-3829
Carroll, R.C.; Lockhart, M.S.; Taylor, F.B. 1984: Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma Journal of Laboratory and Clinical Medicine 103(5): 695-703
Mikhalev, V.V. 1971: Blood coagulation and the physico-chemical properties of the fibrin-thrombocytic structure of the clot in patients with post-infarct cardiosclerosis Terapevticheskii Arkhiv 43(8): 99-102
Itoh, J.; Nakagawa, H.; Sasaki, H.; Takahashi, T. 1985: A fibrin clot containing of anticancer drug for intra-arterial chemo-embolization therapy. (2) Chemotherapeutic effects on a model hepatoma using VX-2 carcinoma in rabbits Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(2): 258-264
Kurokawa, T.; Iwasa, S.; Kakinuma, A.; Stassen, J.M.; Lijnen, H.R.; Collen, D. 1991: Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activator Thrombosis and Haemostasis 66(6): 684-693
Gavrish, I.N. 1970: Effect of tryptic hydrolysates of fibrin and fibrinogen on polymerization of monomer fibrin Ukrains'kyi Biokhimichnyi Zhurnal 42(6): 736-742